Cray Awarded $48 Million Contract From the Korea Institute of Science and Technology Information
Sep 21, 2017 20:05 pm UTC| Business
SEATTLE, Sept. 21, 2017 -- Global supercomputer leader Cray Inc. (Nasdaq:CRAY) today announced the Korea Institute of Science and Technology Information (KISTI) has awarded the Company a contract valued at more than $48...
Calithera Biosciences Appoints Blake Wise to Board of Directors
Sep 21, 2017 20:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Sept. 21, 2017 -- Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor...
SMART Global Holdings Appoints Randy Furr to its Board of Directors
Sep 21, 2017 20:05 pm UTC| Business
NEWARK, Calif., Sept. 21, 2017 -- SMART Global Holdings, Inc. (“SMART”) (NASDAQ:SGH), the parent company of SMART Modular Technologies, Inc., today announced the appointment of Randy W. Furr, Executive Vice President...
Galapagos increases share capital through warrant exercises
Sep 21, 2017 20:01 pm UTC| Business
Mechelen, Belgium; 21 September 2017, 22.00 CET; regulated information - Galapagos NV (Euronext NASDAQ: GLPG) announces a share capital increase arising from warrant exercises. Galapagos issued 28,100 new ordinary...
INSYS Therapeutics Hires First Corporate Communications Leader and New Investor Relations Agency
Sep 21, 2017 20:01 pm UTC| Business
PHOENIX, Sept. 21, 2017 -- Insys Therapeutics, Inc. (NASDAQ:INSY) ("INSYS" or "the Company"), today announced the hiring of Joe McGrath as the Company’s Senior Director of Corporate Communications, and the retention of...
VIQ Solutions Announces Next Growth Driver, AI-Assist, the Artificial Intelligence Assistant
Sep 21, 2017 20:01 pm UTC| Business
TORONTO, Sept. 21, 2017 -- VIQ Solutions Inc. (“VIQ”, or the “Company”) (TSX Venture:VQS), a global expert providing a cybersecurity protected technology and service platform for digital evidence capture and content...
Marinus Pharmaceuticals to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 21, 2017 20:01 pm UTC| Business
RADNOR, Pa., Sept. 21, 2017 -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today...